Aura Biosciences, Inc. AURA Proceeds From Issuance Of Warrants
Proceeds From Issuance Of Warrants at other companies
Other financials
Where this comes from
Reported directly by Aura Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfWarrants.
The official record: Aura Biosciences, Inc.’s 10-K, filed March 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Aura Biosciences, Inc.'s proceeds from issuance of warrants.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Aura Biosciences, Inc.'s proceeds from issuance of warrants?
- Aura Biosciences, Inc. (AURA) reported proceeds from issuance of warrants of $3.54M in Q4 2025.
- What does proceeds from issuance of warrants mean?
- Represents the cash inflows received by the company from the issuance of warrants, which grant holders the right to purchase shares at a specified price. This metric highlights the company's ability to raise capital through derivative instruments rather than direct equity offerings. It is a key indicator of alternative financing strategies and potential future dilution.